Issue 18, 2012

Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosannanoparticles for enhancement of its bioavailability

Abstract

Nanochemoprevention by oral consumption was developed by the encapsulation of (−)-epigallocatechin-3-gallate (EGCG) with nanoparticles that were electrostatically assembled from bioactive caseinophosphopeptides and chitosan, which was highly biocompatible and able to enhance the bioavailability of EGCG.

Graphical abstract: Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability

Supplementary files

Article information

Article type
Communication
Submitted
23 Nov 2011
Accepted
07 Jan 2012
First published
10 Jan 2012

Chem. Commun., 2012,48, 2421-2423

Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability

B. Hu, Y. Ting, X. Yang, W. Tang, X. Zeng and Q. Huang, Chem. Commun., 2012, 48, 2421 DOI: 10.1039/C2CC17295J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements